ADXN News

ADDEX raises USD 2.8 million through its ATM agreement and extends cash runway to the fourth quarter 2027

Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness

Addex Shareholders Approve All Resolutions at Annual General Meeting

Addex Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Addex Therapeutics to Report 2026 First Quarter Financial Results and Host Conference Call on June 25, 2026

Addex Convenes Annual General Meeting 2026

Addex Reports Full Year 2025 Financial Results and Provides Corporate Update

Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model

Addex Spin-Out Company Neurosterix on Track to Complete Phase 1 Clinical Study of NTX-253 for Schizophrenia in Q2 2026

Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model